NCT04802876 Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04801095 A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT04792463 Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome Status RECRUITING Phase N/A
NCT04764084 Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT04753996 Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients Status RECRUITING Phase N/A
NCT04742959 Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04727541 Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer Status TERMINATED Phase PHASE2
NCT04717687 Pilot Study on the Evaluation of Irreversible Electroporation Technique in Infiltrating Perihilar Cholangiocarcinoma Status WITHDRAWN Phase NA
NCT04683939 Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04676633 Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy Status COMPLETED Phase PHASE1
NCT04668976 A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Status UNKNOWN Phase PHASE2
NCT04656249 Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer Status COMPLETED Phase PHASE2
NCT04648319 A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma Status TERMINATED Phase PHASE2
NCT04645160 Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT04644315 A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Status TERMINATED Phase PHASE2
NCT04642664 Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer Status COMPLETED Phase PHASE2
NCT04584775 Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care Status WITHDRAWN Phase NA